Monday, September 23, 2019

Latest:

Do no harm: A moral imperative to be the change in healthcare
Early postnatal overnutrition sets the body on a fast track to aging
Recipe: Roasted root vegetables make for simple, healthy side dish
Teens and social media: Tips to encourage responsible use
What to expect within the tumor microenvironment

Baylor College of Medicine Blog Network

Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
PolicyWise
- About PolicyWise
- Follow @BCMEthics on Twitter
Progress Notes
- About Progress Notes
- Connect With Us
bcm.edu

patent

From The Labs

From the labs to patent; osteoarthritis gene-therapy product is moving toward clinical trials

June 18, 2019June 18, 2019 Ana Rodríguez 0 Comments clinical trial, gene therapy, Il-1, Osteoarthritis, patent, Research

More than 30 million people in the United States alone are affected by osteoarthritis (OA), a degenerative joint disease, and

PolicyWise

Licensing ‘CRISPR’ patents to promote public interests

January 18, 2017January 18, 2017 Clarice 0 Comments Center for Medical Ethics and Health Policy, Christi Guerrini, CRISPR, patent

Designer babies. Super soldiers. Unstable ecosystems. These are just a few of the feared outcomes from uncontrolled application of the

From the Labs features a soil-dwelling amoeba interacting with bacteria. Learn what happens to these amoebae in the absence of lectin.

Listen to the Body of Work Podcast

Body of Work, the Baylor College of Medicine podcast, is an exploration of health topics in the news and important scientific matters featuring insights from experts at Baylor. Listen on your preferred platform.